Cancer diagnosis causes steep rise in out-of-pocket costs for the insured

New research underscores the financial burden a cancer diagnosis can impose on patients.

Cancer diagnosis significantly raises out-of-pocket costs for insured patients

A recent study published in JAMA Open Network reveals that a cancer diagnosis results in a significant increase in out-of-pocket costs for privately insured patients. On average, patients see their monthly expenses surge by $592.53 in the six months following their diagnosis. This financial burden is particularly pronounced among younger patients, often before they qualify for Medicare. As cancer progresses, these costs escalate, with patients at stage 0 facing an increase of $462 per month, and those at stage 4 incurring an additional $719.97. The research emphasizes the impact of treatment intensity at advanced stages, indicating a strong link between cancer severity and financial strain, which highlights an urgent need for policy reform to alleviate such burdens on patients.

This research paints a concerning picture of the financial toll cancer exacts on individuals, particularly those with private insurance. The rising costs as the disease advances underscore the necessity for systemic changes in healthcare policies, such as implementing paid sick leave and improving financial assistance for patients undergoing treatment. As more people in younger age groups are diagnosed, these findings indicate that healthcare reform must prioritize coverage and support for those facing significant financial pressures due to their conditions.

Highlights

The study's findings challenge policymakers to reassess the financial landscape surrounding cancer care.